
[Press Release] InVivo Biosystems and Thaena Announce Novel Metabolite Research Platform With Compelling Longevity and Healthspan Implications and Outcomes
– InVivo Biosystems, experts in preclinical in vivo testing and CRISPR genome editing, and Thaena Inc., a science-based wellness company developing novel microbiome-based therapies, today